Each year at the American Society for Laser Medicine & Surgery (ASLMS) Annual Conference, a number of prestigious awards are presented to individuals whose achievements have made a significant contribution to the field of lasers and energy-based devices for medicine.
AVAVA congratulates our CTO, Jay Bhawalker, PhD as the 2023 winner of the Dr. Horace Furumoto Innovations Professional Development Distinguished Contributor Award.
AVAVA Receives FDA 510(k) Clearance for its First-in-Class High Energy Skin Renewal Platform – MIRIA Skin Treatment System
WALTHAM, Mass., Wednesday, December 07, 2022 — AVAVA Inc. (“AVAVA” or the “Company”), a disruptive medical aesthetics platform company advancing a new class of focused intradermal laser products for breakthrough treatments of all skin tones, today announced that its MIRIA Skin Treatment System (“MIRIA system”) has received FDA 510(k) clearance for prevention (pre-rejuvenation) and treatment (rejuvenation) of skin aging. This marks a first of its kind regulatory clearance for a high energy focused intradermal laser, powered by Focal Point Technology™, that delivers energy at any depth in the skin with pinpoint accuracy, making it ideal for patients with darker skin tones.
AVAVA Receives FDA 510(k) Clearance to Treat Benign Pigment Lesions, Including Hyperpigmentation
Waltham, Mass., Wednesday, August 17, 2022 — AVAVA Inc., (“AVAVA” or the “Company”), a disruptive medical aesthetics technology platform company providing breakthrough treatments for all skin tones, today announced that its AVAVA pigment disorder product has received FDA 510(k) clearance to treat benign pigmented lesions of the skin, including hyperpigmentation. This clearance marks AVAVA’s second received from the FDA for its new class of focused intradermal laser products powered by Focal Point Technology™ to deliver energy at any depth with pinpoint accuracy for ideal patient outcomes
AVAVA’s Breakthrough Aesthetic Treatment for ALL Skin Tones Wins Prestigious Innovation Tank Challenge during 23rd IMCAS Annual World Congress
Waltham, Mass., Wednesday, June 15, 2022 – AVAVA Inc., a disruptive aesthetic platform company, announced today that it was awarded first place in the prestigious Innovation Tank Challenge during the 23rd International Master Course on Aging Science (IMCAS) Annual World Congress. The award recognized AVAVA’s non-invasive breakthrough procedure that safely and effectively prevents and treats skin aging, and pigmentary conditions, for all skin tones.